Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview.
Kruschewsky WLL
,
Massaroni-Peçanha P
,
Maifrede SB
,
Leite MS
,
Pôssa TAL
,
Alberto-Lei F
,
Cayô R
,
Peçanha PM
,
Gonçalves SS
.
???displayArticle.abstract???
Trichosporon spp. are a constituent of the normal flora of humans that can cause both superficial and invasive infections, mainly in immunocompromised and immunocompetent hosts, respectively. Herein, we a report of Trichosporon asahii causing subcutaneous fungal infection (SFI) in an immunocompetent patient after carpal tunnel surgery. Although susceptible to fluconazole, the treatment of SFI failed even using high doses of this azole. The skin lesion improved following the administration of voriconazole. We conducted a literature minireview searching reports on SFI in immunocompetent patients to check for epidemiological, diagnostic, therapeutic, and outcome characteristics. A total of 32 cases were reported. Despite being uncommon, the clinical suspicion and early diagnosis of SFI in immunocompetent patients undergoing previous surgery are important. Our study indicated that the azoles are the most active antifungal agents against Trichosporon spp., except for fluconazole, and voriconazole can be considered the first therapeutic option.
Anaissie,
Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
1992, Pubmed
Anaissie,
Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
1992,
Pubmed
Arendrup,
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.
2014,
Pubmed
Baka,
Fatal lower limb infection by Trichosporon asahii in an immunocompetent patient.
2013,
Pubmed
Bongomin,
Trichosporon japonicum Fungemia and Ventricular Assist Device Infection in an Immunocompetent Patient.
2019,
Pubmed
Capoor,
Trichosporon mucoides causing onychomycosis in an immunocompetent patient.
2015,
Pubmed
Castano,
Trichosporonosis
2024,
Pubmed
Cawley,
Trichosporon beigelii infection: experience in a regional burn center.
2000,
Pubmed
Chan,
Deep-seated trichosporonosis in an immunocompetent patient: a case report of uterine trichosporonosis.
2000,
Pubmed
Colombo,
Current knowledge of Trichosporon spp. and Trichosporonosis.
2011,
Pubmed
Davies,
Sternal wound infection by Trichosporon inkin following cardiac surgery.
2006,
Pubmed
Desnos-Ollivier,
Epidemiological investigation for grouped cases of Trichosporon asahii using whole genome and IGS1 sequencing.
2020,
Pubmed
Ding,
Trichosporon Asahii fungaemia in an immunocompetent polytrauma patient who received multiple antibiotics.
2020,
Pubmed
Fan,
Primary cutaneous trichosporonosis caused by Trichosporon dermatis in an immunocompetent man.
2011,
Pubmed
Girmenia,
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.
2005,
Pubmed
Greenberg,
Postoperative Trichosporon beigelii soft tissue infection.
1989,
Pubmed
Guého,
Trichosporon on humans: a practical account.
1994,
Pubmed
Hirschi,
Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient.
2012,
Pubmed
Janagond,
Trichosporon inkin, an unusual agent of fungal sinusitis: a report from south India.
2012,
Pubmed
Khan,
Trichosporon asahii urinary tract infection in immunocompetent patients.
2015,
Pubmed
Kim,
Successful treatment of septic shock with purpura fulminans caused by Trichosporon asahii in an immunocompetent patient.
2007,
Pubmed
Kim,
Chronic cutaneous disseminated Trichosporon asahii infection in a nonimmunocompromised patient.
2008,
Pubmed
Kumar,
Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review.
2015,
Pubmed
Lacasse,
Trichosporon mucoides fungemia in a liver transplant recipient: case report and review.
2009,
Pubmed
Liu,
Towards an integrated phylogenetic classification of the Tremellomycetes.
2015,
Pubmed
Lo Passo,
Transmission of Trichosporon asahii oesophagitis by a contaminated endoscope.
2001,
Pubmed
Mada,
Trichosporon asahii septic thrombophlebitis following lower extremity amputation in an immunocompetent host.
2018,
Pubmed
Martínez Muñiz,
Chronic lung infection caused by Trichosporon mycotoxinivorans and tricosporin mucoides in an immunocompetent cystic fibrosis patient.
2016,
Pubmed
Miceli,
Emerging opportunistic yeast infections.
2011,
Pubmed
Milan,
Trichosporon inkin meningitis in Northeast Brazil: first case report and review of the literature.
2018,
Pubmed
Miró,
Trichosporon beigelii fungemia and metastatic pneumonia in a trauma patient.
1994,
Pubmed
Mohd Tap,
Subcutaneous Infection Associated with Trichosporon ovoides: A Case Report and Review of Literature.
2016,
Pubmed
Moreno-Coutiño,
Necrotic ulcer caused by Trichosporon asahii in an immunocompetent adolescent.
2012,
Pubmed
Noy,
Cutaneotrichosporon (Trichosporon) debeurmannianum associated with a subcutaneous mycotic cyst successfully treated with voriconazole.
2020,
Pubmed
Ortega-Springall,
Onycholysis and Chromonychia: A Case Caused by Trichosporon inkin.
2016,
Pubmed
Otsuka,
Facial granuloma associated with Trichosporon cutaneum infection.
1986,
Pubmed
Paphitou,
In vitro antifungal susceptibilities of Trichosporon species.
2002,
Pubmed
Pulvirenti,
Superficial cutaneous Trichosporon asahii infection in an immunocompetent host.
2006,
Pubmed
Ramos,
Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism.
2004,
Pubmed
Rastogi,
Non-healing ulcer due to Trichosporon loubieri in an immunocompetent host and review of published reports.
2013,
Pubmed
Reddy,
Breast implant infection caused by Trichosporon beigelii.
2002,
Pubmed
Rosario Medina,
Pigeons and their droppings as reservoirs of Candida and other zoonotic yeasts.
2017,
Pubmed
Song,
Trichosporon inkin subcutaneous infection in a rheumatoid arthritis patient.
2007,
Pubmed
Sood,
Urinary tract infection by Trichosporon asahii.
2006,
Pubmed
Sugita,
Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis.
2004,
Pubmed
Tawara,
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.
2000,
Pubmed
Tian,
Delayed fungal infection following augmentation mammoplasty in an immunocompetent host.
2007,
Pubmed
Tokimatsu,
The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
2007,
Pubmed
Uzun,
In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates.
1997,
Pubmed
Walsh,
Trichosporonosis.
1989,
Pubmed
Walsh,
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.
1990,
Pubmed
Watson,
Brain abscess due to Trichosporon cutaneum.
1970,
Pubmed
Xiaoxi,
Trichosporon inkin causing subcutaneous sinus tract: Successfully treated by oral and ultrasound-guided intralesional itraconazole therapy.
2017,
Pubmed
Yamamoto,
Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents.
1997,
Pubmed
Yun,
Cutaneous abscess by Trichosporon asahii developing on a steroid injection site in a healthy adult.
2006,
Pubmed
Zuo,
Trichosporon asahii infection after total knee arthroplasty: A case report and review of the literature.
2015,
Pubmed
